FGF21 and obesity due to melanocortin 4 receptor deficiency: Although FGF21 has several beneficial effects for glucose and lipid metabolism [78], circulating FGF21 levels are paradoxically increased in humans with obesity, metabolic syndrome [79,80], and NAFLD [81,82,83].